During the past decade, Hacettepe Uni Medical Faculty; Hematology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hacettepe Uni Medical Faculty; Hematology" are "Non-Hodgkin's Lymphoma" (2 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Hacettepe Uni Medical Faculty; Hematology" in a lesser frequency.

Most popular intervention types in "Hacettepe Uni Medical Faculty; Hematology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "rituximab [MabThera/Rituxan]" (2 trials), "CHOP" (1 trials), "Chemotherapy (Induction Period)" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hacettepe Uni Medical Faculty; Hematology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hacettepe Uni Medical Faculty; Hematology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hacettepe Uni Medical Faculty; Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hacettepe Uni Medical Faculty; Hematology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".